Identification of new triarylethylene oxyalkanoic acid analogues as bone selective estrogen mimetics
Now, Winfrey says, just as she takes blood pressure medication to control a disease that runs in her family, she also takes a GLP-1 drug to control her enough point (she has declined to specify which drug she takes, but so far there are only two on the market: semaglutide from Novo Nordisk, and tirzepatide from Eli Lilly)
Knapp DW, Richardson RC, DeNicola DB, Long GG, Blevins WE
The absence of sufficient L-carnitine makes the body have difficulties in carrying fatty acids into the mitochondria
We need to focus on preventing these diseases to begin with
Both are approved medications in Russia and Ukraine for specific clinical indications, but remain research-only compounds in Western markets